These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Aspergillus nidulans mutant lacking alpha-(1,3)-glucan, melanin, and cleistothecia.
    Author: Polacheck I, Rosenberger RF.
    Journal: J Bacteriol; 1977 Nov; 132(2):650-6. PubMed ID: 334748.
    Abstract:
    A mutation in Aspergillus nidulans led to a loss of both melanin and alpha-(1,3)-glucan, a major wall polysaccharide. In addition, the mutation prevented the formation of cleistothecia. Mutant walls contained increased amounts of beta-(1,3)-glucan and galactose polymers, and electron micrographs indicated that they had lost the outermost wall layer. Such walls were more readily digested by lytic enzymes, and this increased susceptibility to hydrolysis was due to the absence of alpha-(1,3)-glucan and not of melanin. The pleiotropic effects of the mutation are discussed, with particular reference to the hypothesis that alpha-(1,3)-glucan acts as the endogenous carbon source for biosynthetic processes in the stationary phase of growth. In this view, glucan synthesis would be the primary target of the mutation, and the absence of glucan would result in the lack of melanin and cleistothecia, formed after nutrients are exhausted. Two other mutations that lowered themycelial alpha-(1,3)-glucan content also inhibited melanin and cleistothecia production.
    [Abstract] [Full Text] [Related] [New Search]